Breaking News Instant updates and real-time market news.

REGN

Regeneron

$475.79

-10.11 (-2.08%)

, SNY

Sanofi

$48.20

0.1 (0.21%)

08:08
06/12/17
06/12
08:08
06/12/17
08:08

Regeneron's Dupixent tracking well above consensus, says Leerink

Leerink analyst Geoffrey Porges says prescription trends suggest Regeneron (REGN) and Sanofi's (SNY) Dupixent will "comfortably exceed" current sell-side consensus expectations for this quarter and year. After 10 weeks, the prescription launch trajectory "remains very robust," Porges tells investors in a research note. The analyst views his Q2 sales estimate of $31M, versus the $16M consensus, as "reasonable," and feels full year sales of $200M-300M, versus the consensus of $135-$140M, is likely. He reiterates an Outperform rating on Regeneron shares.

REGN

Regeneron

$475.79

-10.11 (-2.08%)

SNY

Sanofi

$48.20

0.1 (0.21%)

REGN Regeneron
$475.79

-10.11 (-2.08%)

05/23/17
JEFF
05/23/17
NO CHANGE
Target $418
JEFF
Hold
Regeneron approval expected, but positive, says Jefferies
Jefferies analyst Biren Amin says that while the FDA approval of Regeneron's (REGN) Kevzara for the treatment of adult patients with moderate to severe active rheumatoid arthritis was expected, it is a positive. The label is in line with expectations and includes a risk of serious infections similar to Humira's (HUM) label, Amin tells investors in a research note. He notes that Regeneron disclosed a $39,000 wholesale acquisition cost for Kevzara, which is 30% lower than TNF competitors. The analyst has a Hold rating on Regeneron with a $418 price target.
05/05/17
LEER
05/05/17
NO CHANGE
Target $493
LEER
Outperform
Regeneron price target raised to $493 from $448 at Leerink
Leerink analyst Geoffrey Porges raised his price target for Regeneron to $493 from $448 following quarterly results, and given the strength of peer company multiples and greater conviction about long-term profitability. The analyst reiterates an Outperform rating on the shares.
05/05/17
ADAM
05/05/17
UPGRADE
Target $484
ADAM
Buy
Regeneron upgraded to Buy at Canaccord
As reported previously, Canaccord analyst John Newman upgraded Regeneron to Buy from Hold. The analyst cited the strong investor sentiment toward the Dupixent launch, which he believes will drive the shares higher into Q2 and Q3 earnings. He also believes there will be less focus on Eylea revenues, despite slowing growth. Newman raised his price target to $484 from $375 on Regeneron shares.
05/05/17
UBSW
05/05/17
NO CHANGE
Target $489
UBSW
Buy
Regeneron price target raised to $489 from $446 at UBS
UBS analyst Carter Gould raised his price target on Regeneron to $489 from $446 following Q1 results. The analyst lowered his Eylea U.S. sales estimates based on Q1 trends, but he saw positives in the Dupixent update, including strong demand in atopic dermatitis. Also, the company has seen positive proof-of-concept data in eosinophilic esophagitis, which he noted was not in Street models. Gould reiterated his Buy rating on Regeneron shares.
SNY Sanofi
$48.20

0.1 (0.21%)

06/06/17
WELS
06/06/17
NO CHANGE
WELS
Amazon may be the next threat to drug pricing, says Wells Fargo
After CNBC recently reported that Amazon (AMZN) is considering going into the prescription pharmacy business in the U.S., Wells Fargo surveyed nearly 2,900 U.S. adults and found that 54% of those polled said they would use or would probably use "Amazon Pharmacy." While the e-commerce giant has not confirmed its U.S. pharmacy interest, if it did enter the market analyst David Maris believes it could see fast adoption and "usher in a new age of price transparency." Maris also wonders if pharmacy "may be just the beginning" and if Amazon eyes the "even larger prize" of fully integrated digital healthcare. Publicly traded large-cap pharmaceuticals companies include AstraZeneca (AZN), Bristol-Myers (BMY), Eli Lilly (LLY), GlaxoSmithKline (GSK), Johnson & Johnson (JNJ), Merck (MRK), Novartis (NVS), Pfizer (PFE), Roche (RHHBY) and Sanofi (SNY). Publicly traded retail pharmacy operators include CVS Health (CVS), Walgreens (WBA), Fred's (FRED) and Rite Aid (RAD).
05/11/17
BREN
05/11/17
DOWNGRADE
BREN
Hold
Sanofi downgraded to Hold from Buy at Berenberg
Berenberg analyst Alister Campbell downgraded Sanofi to Hold citing valuation.
04/11/17
04/11/17
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Disney (DIS) upgraded to Conviction Buy from Buy at Goldman with analyst Drew Borst saying that the success of "Beauty and the Beast" has increased his confidence in his forecast that FY18 EPS growth will accelerate given the company's promising film slate and its read-through to consumer products. He also sees accelerating profit growth at ESPN given normalizing NBA costs and predicts record results for the Theme Parks segment. Borst keeps a $138 price target on Disney shares. 2. McDonald's (MCD) upgraded to Buy from Neutral at Cleveland Research. 3. Yelp (YELP) upgraded to Overweight from Sector Weight at Pacific Crest with analyst Brad Erickson saying his checks with local ad customers indicate Yelp's core franchise is healthy and appears insulated from larger competitors like Google (GOOG, GOOGL) and Facebook (FB). 4. Toll Brothers (TOL) upgraded to Outperform from Sector Perform at RBC Capital with analyst Robert Wetenhall citing "solid demand,strong execution, proven management, a strong luxury housing business, and consistent earnings." 5. Sanofi (SNY) upgraded to Neutral from Underweight at JPMorgan with analyst Richard Vosser saying he no longer sees downside to consensus estimates. The pressure on the diabetes business now seems largely reflected in estimates, Vosser tells investors in a research note. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
04/11/17
JPMS
04/11/17
UPGRADE
JPMS
Neutral
Sanofi upgraded to Neutral from Underweight at JPMorgan
JPMorgan analyst Richard Vosser upgraded Sanofi to Neutral saying he no longer sees downside to consensus estimates. The pressure on the diabetes business now seems largely reflected in estimates, Vosser tells investors in a research note. The analyst raised his price target for the shares to EUR 87 from EUR 71.

TODAY'S FREE FLY STORIES

YPF

YPF

$20.14

0.28 (1.41%)

10:55
08/22/17
08/22
10:55
08/22/17
10:55
Options
YPF put volume heavy and directionally bearish »

Bearish flow noted in YPF…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CMCO

Columbus McKinnon

$30.54

-0.29 (-0.94%)

10:52
08/22/17
08/22
10:52
08/22/17
10:52
Conference/Events
Columbus McKinnon management to meet with Roth Capital »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Aug

  • 29

    Aug

  • 29

    Nov

  • 30

    Nov

BRK.A

Berkshire Hathaway

$269,830.00

1290 (0.48%)

, BRK.B

Berkshire Hathaway

$179.30

0.96 (0.54%)

10:44
08/22/17
08/22
10:44
08/22/17
10:44
Hot Stocks
S&P removes Berkshire Hathaway from CreditWatch, calls outlook 'stable' »

S&P Global Ratings…

BRK.A

Berkshire Hathaway

$269,830.00

1290 (0.48%)

BRK.B

Berkshire Hathaway

$179.30

0.96 (0.54%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BAC

Bank of America

$23.78

0.4 (1.71%)

10:40
08/22/17
08/22
10:40
08/22/17
10:40
Options
Bank of America calls active as shares see strength »

Bank of America calls…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

10:40
08/22/17
08/22
10:40
08/22/17
10:40
General news
Treasury Option Action: a build-up of bullish call butterflies »

Treasury Option Action: a…

WILC

G. Willi-Food

$6.49

-0.0209 (-0.32%)

10:35
08/22/17
08/22
10:35
08/22/17
10:35
Hot Stocks
G. Willi-Food names Zwi Williger as co-chairman »

G. Willi-Food…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PVG

Pretium Resources

$8.37

-0.18 (-2.11%)

10:35
08/22/17
08/22
10:35
08/22/17
10:35
Options
Pretium Resources put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

10:35
08/22/17
08/22
10:35
08/22/17
10:35
General news
Oil Action: NYMEX crude »

Oil Action: NYMEX crude…

MDT

Medtronic

$81.88

-1.645 (-1.97%)

, DXCM

Dexcom

$73.06

-0.14 (-0.19%)

10:34
08/22/17
08/22
10:34
08/22/17
10:34
Recommendations
Medtronic, Dexcom, TNDM analyst commentary  »

Medtronic challenges in…

MDT

Medtronic

$81.88

-1.645 (-1.97%)

DXCM

Dexcom

$73.06

-0.14 (-0.19%)

TNDM

TNDM

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Aug

  • 22

    Aug

  • 06

    Sep

  • 07

    Sep

  • 20

    Sep

TWX

Time Warner

$101.67

-0.44 (-0.43%)

, T

AT&T

$37.63

0.045 (0.12%)

10:34
08/22/17
08/22
10:34
08/22/17
10:34
Periodicals
Time Warner-AT&T deal questioned by Brazil regulator, Bloomberg says »

Brazils antitrust…

TWX

Time Warner

$101.67

-0.44 (-0.43%)

T

AT&T

$37.63

0.045 (0.12%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Sep

FCX

Freeport McMoRan

$15.37

0.6399 (4.34%)

10:32
08/22/17
08/22
10:32
08/22/17
10:32
Technical Analysis
Technical View: Freeport McMoRan breaks through top of recent range »

The stock was last up…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DSW

DSW

$18.92

3.23 (20.59%)

10:32
08/22/17
08/22
10:32
08/22/17
10:32
Downgrade
DSW rating change  »

DSW downgraded to Hold…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Aug

RDFN

Redfin

$27.56

0.86 (3.22%)

, EGN

Energen

$50.21

0.65 (1.31%)

10:29
08/22/17
08/22
10:29
08/22/17
10:29
Initiation
On The Fly: Top five analyst initiations »

Catch up on the…click here.

RDFN

Redfin

$27.56

0.86 (3.22%)

EGN

Energen

$50.21

0.65 (1.31%)

PXD

Pioneer Natural

$128.63

0.69 (0.54%)

RVNC

Revance

$22.70

-0.45 (-1.94%)

PCRX

Pacira

$35.75

-0.05 (-0.14%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Aug

  • 06

    Sep

  • 25

    Sep

  • 02

    Nov

MYL

Mylan

$30.44

-0.28 (-0.91%)

, BIP

Brookfield Infrastructure

$44.78

0.135 (0.30%)

10:29
08/22/17
08/22
10:29
08/22/17
10:29
Downgrade
On The Fly: Top five analyst downgrades »

Catch up on today's…click here.

MYL

Mylan

$30.44

-0.28 (-0.91%)

BIP

Brookfield Infrastructure

$44.78

0.135 (0.30%)

GMRE

Global Medical REIT

$8.38

-0.6 (-6.68%)

NXTM

NxStage Medical

$29.11

-0.14 (-0.48%)

FMS

Fresenius Medical

$46.69

0.37 (0.80%)

HKMPY

Hikma

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Aug

  • 03

    Sep

  • 06

    Sep

  • 08

    Sep

  • 15

    Sep

  • 09

    Oct

BABA

Alibaba

$171.47

2.22 (1.31%)

, VMW

VMware

$98.97

1.96 (2.02%)

10:29
08/22/17
08/22
10:29
08/22/17
10:29
Upgrade
On The Fly: Top five analyst upgrades »

Catch up on today's…click here.

BABA

Alibaba

$171.47

2.22 (1.31%)

VMW

VMware

$98.97

1.96 (2.02%)

AMZN

Amazon.com

$953.29

-5.18 (-0.54%)

EL

Estee Lauder

$106.53

0.05 (0.05%)

TPX

Tempur Sealy

$62.42

0.91 (1.48%)

WUBA

58.com

$63.80

-0.34 (-0.53%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Aug

  • 24

    Aug

  • 24

    Aug

  • 27

    Aug

FEYE

FireEye

$13.77

-0.21 (-1.50%)

10:25
08/22/17
08/22
10:25
08/22/17
10:25
Options
FireEye call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Sep

  • 11

    Sep

  • 19

    Sep

VMW

VMware

$99.09

2.08 (2.14%)

, AMZN

Amazon.com

$953.29

-5.18 (-0.54%)

10:23
08/22/17
08/22
10:23
08/22/17
10:23
Hot Stocks
Deutsche ups VMware on slower than expected enterprise move to public cloud »

Deutsche Bank upgraded…

VMW

VMware

$99.09

2.08 (2.14%)

AMZN

Amazon.com

$953.29

-5.18 (-0.54%)

MSFT

Microsoft

$72.15

-0.34 (-0.47%)

ORCL

Oracle

$49.11

0.205 (0.42%)

RHT

Red Hat

$102.19

-0.465 (-0.45%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Aug

  • 24

    Aug

  • 24

    Aug

  • 27

    Aug

  • 05

    Sep

TWX

Time Warner

$101.80

-0.31 (-0.30%)

, T

AT&T

$37.77

0.1899 (0.51%)

10:21
08/22/17
08/22
10:21
08/22/17
10:21
Periodicals
Time Warner, AT&T deal questioned by Brazil antitrust agency, Bloomberg says »

Shares of Time Warner…

TWX

Time Warner

$101.80

-0.31 (-0.30%)

T

AT&T

$37.77

0.1899 (0.51%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Sep

SHLD

Sears

$8.55

-0.1 (-1.16%)

, AMZN

Amazon.com

$953.29

-5.18 (-0.54%)

10:19
08/22/17
08/22
10:19
08/22/17
10:19
Hot Stocks
Sears jumps after announcing latest licensing deals for Kenmore, DieHard brands »

Shares of Sears Holdings…

SHLD

Sears

$8.55

-0.1 (-1.16%)

AMZN

Amazon.com

$953.29

-5.18 (-0.54%)

LOW

Lowe's

$75.27

1.42 (1.92%)

HD

Home Depot

$150.33

1.13 (0.76%)

BBY

Best Buy

$61.37

0.9185 (1.52%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Aug

  • 23

    Aug

  • 24

    Aug

  • 24

    Aug

  • 29

    Aug

  • 19

    Sep

  • 21

    Nov

$NSD

NASDAQ Market Internals

10:17
08/22/17
08/22
10:17
08/22/17
10:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PULM

Pulmatrix

$1.67

-0.03 (-1.76%)

10:16
08/22/17
08/22
10:16
08/22/17
10:16
Hot Stocks
Pulmatrix patent for respirable tiotropium dry powders posted to USPTO site 

Reference Link

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

10:16
08/22/17
08/22
10:16
08/22/17
10:16
Technical Analysis
NYSE market internals summary »

Volume is below average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

10:15
08/22/17
08/22
10:15
08/22/17
10:15
General news
U.S. Richmond Fed manufacturing index was flat at 14 in August »

U.S. Richmond Fed…

AVGO

Broadcom

$249.62

0.25 (0.10%)

10:10
08/22/17
08/22
10:10
08/22/17
10:10
Options
Bullish option play in Broadcom ahead of earnings »

Bullish option play in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Aug

CARB

Carbonite

$19.10

-0.15 (-0.78%)

10:05
08/22/17
08/22
10:05
08/22/17
10:05
Hot Stocks
Carbonite annonces strategic referral deal with Code42 »

Carbonite announced it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.